CDI System 100 Monitoring System
510(k) K902654
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK902654 | Date5 Nov 1990 | StatusActive |
Recalls
-
- Terminated Z-2610-2011
Terumo discovered through its own testing that the presence of electromagnetic interference (EMI) in the operating room may affect the accuracy of the values displayed by the CDI"101 Hematocrit/Oxygen Saturation Monitoring System: hematocrit (HCT), hemoglobin (Hgb) and Oxygen Saturation.
-
- Terminated Z-2683-2011
- Terminated Z-2684-2011
Inaccurate readings may result after Methylene Blue, an intravascular dye, is administered to the patient. The presence of Methylene Blue may interfere with the readings from the shunt sensor for the CDI 500 system in a way that would cause inaccurate pH values. Because the pH value is used to calculate other values, these parameters could also be affected by the presence of Methylene Blue: K
-
- Terminated Z-1943-2011
- Terminated Z-1944-2011
Inaccurate result. Possibility for displayed values for potassium, CO2, hematocrit, O2 saturation, pH, hemoglobin and other measured blood parameters to be inaccurate.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Cdi (Tm) System 100 Monitoring System
- 510(k) Number
- FDA Product Code
- DTY
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.4410
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 6 Oct 2026
The CDI System 100 Monitoring System is an in-line blood-gas sensor designed for use during cardiopulmonary bypass procedures. It functions as a cardiovascular monitoring device to provide real-time data on blood-gas parameters.
This device is classified as a Class 2 medical device under regulation number 870.4410. It received FDA 510(k) clearance on November 5, 1990, under the traditional clearance pathway.
Other devices from 3M Health Care, Ltd.
Questions
AI-generated answers, 6 Oct 2026
What is the primary clinical application of the CDI System 100 Monitoring System?
The CDI System 100 is an in-line blood-gas sensor specifically designed to provide real-time monitoring of blood-gas parameters during cardiopulmonary bypass procedures.
What is the regulatory status of the CDI System 100?
The device is classified as a Class 2 medical device under regulation number 870.4410 and received FDA 510(k) clearance on November 5, 1990, through the traditional pathway.
Who is the manufacturer of the CDI System 100 Monitoring System?
The system is manufactured by 3M Health Care, Ltd., based in Irvine, California, and is categorized under the cardiovascular medical specialty.